Bionano Genomics Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
97
- Stock Symbol
-
BNGO
- Investments
-
3
- Share Price
-
$1.00
- (As of Friday Closing)
Bionano Genomics General Information
Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Contact Information
Website
www.bionano.comCorporate Office
- 9540 Towne Centre Drive
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 9540 Towne Centre Drive
- Suite 100
- San Diego, CA 92121
- United States
Bionano Genomics Timeline
Bionano Genomics Stock Performance
As of 13-Nov-2026, Bionano Genomics’s stock price is $1.00. Its current market cap is $14M with 14M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.00 | $1.04 | $0.97 - $2.23 | $14M | 14M | 966K | -$3.02 |
Bionano Genomics Financials Summary
As of 30-Jun-2026, Bionano Genomics has a trailing 12-month revenue of $30.2M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 15,576 | 11,183 | 28,914 | 19,968 |
| Revenue | 30,176 | 28,508 | 30,776 | 36,116 |
| EBITDA | (21,758) | (21,194) | (97,486) | (224,829) |
| Net Income | (32,162) | (26,395) | (112,017) | (232,493) |
| Total Assets | 47,591 | 73,584 | 76,670 | 214,404 |
| Total Debt | 6,704 | 6,915 | 6,935 | 9,610 |
Bionano Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionano Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Bionano Genomics Comparisons
Industry
Financing
Details
Bionano Genomics Competitors (29)
One of Bionano Genomics’s 29 competitors is Cytek Biosciences, a Formerly VC-backed company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytek Biosciences | Formerly VC-backed | Fremont, CA | ||||
| 10x Genomics | Formerly VC-backed | Pleasanton, CA | ||||
| Pacific BioSciences of California | Formerly VC-backed | Menlo Park, CA | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA | ||||
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA |
Bionano Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bionano Genomics Patents
Bionano Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026222244-A2 | Detecting homologous recombination deficiency in breast and ovarian cancers by genome mapping | Pending | 16-Apr-2025 | ||
| WO-2026188084-A1 | Servo focuser operation | Pending | 06-Mar-2025 | ||
| CA-232666-S | Cartridge for optical genome mapping | Active | 17-Jan-2024 | ||
| CA-232665-S | Cartridge for optical genome mapping | Active | 18-Jul-2023 | ||
| US-D1109360-S1 | Cartridge for optical genome mapping | Active | 18-Jul-2023 |
Bionano Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bionano Genomics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bionano Genomics Acquisitions (3)
Bionano Genomics’s most recent deal was a Merger/Acquisition with Purigen Biosystems for . The deal was made on 30-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Purigen Biosystems | 30-Nov-2022 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| BioDiscovery | 12-Oct-2021 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Lineagen | 21-Aug-2020 | Merger/Acquisition | Other Healthcare Technology Systems |
Bionano Genomics ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
25.47 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Bionano Genomics FAQs
-
When was Bionano Genomics founded?
Bionano Genomics was founded in 2003.
-
Where is Bionano Genomics headquartered?
Bionano Genomics is headquartered in San Diego, CA.
-
What is the size of Bionano Genomics?
Bionano Genomics has 97 total employees.
-
What industry is Bionano Genomics in?
Bionano Genomics’s primary industry is Discovery Tools (Healthcare).
-
Is Bionano Genomics a private or public company?
Bionano Genomics is a Public company.
-
What is Bionano Genomics’s stock symbol?
The ticker symbol for Bionano Genomics is BNGO.
-
What is the current stock price of Bionano Genomics?
As of 13-Nov-2026 the stock price of Bionano Genomics is $1.00.
-
What is the current market cap of Bionano Genomics?
The current market capitalization of Bionano Genomics is $14M.
-
What is Bionano Genomics’s current revenue?
The trailing twelve month revenue for Bionano Genomics is $30.2M.
-
Who are Bionano Genomics’s competitors?
Cytek Biosciences, 10x Genomics, Pacific BioSciences of California, Standard BioTools, and Twist Bioscience are some of the 29 competitors of Bionano Genomics.
-
What is Bionano Genomics’s annual earnings per share (EPS)?
Bionano Genomics’s EPS for 12 months was -$3.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
